Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technolo-gies to basic science cancer researchers – to create an environ-ment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imag-ing adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

Photo of Dr. Gambhir speaking at 2012 TedXStanford

Dr. Gambhir's TedXStanford lecture
"Molecular Spies for Early Disease Detection"

News & Events

Recent News

Farewell Dr.'s Ferrara, He, and Lee

June 20, 2017

2017 Distinguished Investigator Dr. Juergen Willmann

June 6, 2017

Raiyan Zaman, PhD, Received 2017 SNMMI Henry N. Wagner Jr., MD, Best Paper Award

June 1, 2017

Amin Aalipour Named 2017 Paul & Daisy Soros Fellow

May 30, 2017

Join us at the 2017 World Molecular Imaging Congress (WMIC)

May 26, 2017

Dr. Wu Received American Heart Association Merit Award

May 22, 2017

First-in-Human Ultrasound Molecular Imaging in Patients with Breast and Ovarian Lesions

April 3, 2017